CD19 - CD19 molecule Gene

Species: Macaca mulatta

Gene Type: protein coding
Gene ID: 705211

CD19 Products (3)

mRNA Protein Name
XM_001103043.4 XP_001103043.1 B-lymphocyte antigen CD19 isoform X3
XM_015125853.2 XP_014981339.1 B-lymphocyte antigen CD19 isoform X2
XM_015125852.2 XP_014981338.1 B-lymphocyte antigen CD19 isoform X1
Protein Preferred Names Protein Names

B-lymphocyte antigen CD19

Recombinant CD19 Proteins

Cat. No. Product Name Accession Purity
HY-P7833 CD19 Protein, Cynomolgus/Rhesus Macaque (HEK293, Fc) XP_005591597.1/F7F486 (P20-K292) ≥ 95%, as determined by reducing SDS-PAGE.
HY-P75439 CD19 Protein, Cynomolgus/Rhesus Macaque (HEK293, His) XP_005591597.1/F7F486 (Q21-K292) ≥ 95%, as determined by reducing SDS-PAGE.
HY-P76857 CD19 Protein, Cynomolgus/Rhesus Macaque (Biotinylated, HEK293, His) XP_005591597.1/F7F486 (Q21-K292) ≥ 95%, as determined by reducing SDS-PAGE.

Related Agents

  • Approval
  • Clinical Phase
  • Pre-clinical Phase

Approval

Inhibitory Antibodies (2)
Cat. No. Product Name Effect
Purity Rare Diseases
HY-P9963 Blinatumomab Inhibitor 98.78% Unkown
HY-P99113 Inebilizumab Inhibitor 99.00% Unkown

Clinical Phase

Inhibitory Antibodies (13)
Cat. No. Product Name Effect
Purity Phase
HY-P991028 Surovatamig Inhibitor 99.89% Phase 3
HY-P99711 Loncastuximab Inhibitor ≥99.0% Phase 3
HY-P99761 Obexelimab Inhibitor 99.99% Phase 3
HY-P99285 Denintuzumab Inhibitor ≥99.0% Phase 2
HY-P990017 Englumafusp alfa Inhibitor 99.93% Phase 2
HY-P99914 Emfizatamab 95.495% Phase 2
HY-P991900 LY3541860 Inhibitor ≥99.0% Phase 2
HY-P990729 Budoprutug 95.91% Phase 2
HY-P99868 Duvortuxizumab ≥99.0% Phase 1
HY-P990694 Zeripatamig ≥99.0% Phase 1
HY-P991176 RG-6333 Agonist 98.05% Phase 1
HY-P991898 IASO-782 Inhibitor / Phase 1
HY-P991231 DI-B4 Inhibitor / Phase 1

Pre-clinical Phase

Bioactive Molecules (2)
Cat. No. Product Name
Effect
Purity
Rare Diseases
HY-153084A CD19 CAR mRNA (Human) / Unkown
HY-153085 CD19 CAR circRNA / Unkown
Inhibitory Antibodies (10)
Cat. No. Product Name
Effect
Purity
Rare Diseases
HY-P99113A Inebilizumab (FUT8-KO) 99.84% Unkown
HY-P99976 Anti-Mouse CD19 Antibody (1D3) Inhibitor 98.778% Unkown
HY-P990870 Anti-CD19 Antibody (4G7) Inhibitor 98% Unkown
HY-P990571 Coltuximab Inhibitor 98.43% Unkown
HY-P990349 Anti-CD19 Antibody Inhibitor 99.91% Unkown
HY-P991542 GBR-401 Inhibitor / Unkown
HY-P991897 Anti-CD19 Antibody (hA19) / Unkown
HY-P99577 Taplitumomab / Unkown
HY-P991899 IKS03 Antibody / Unkown
HY-P991839 Anti-CD19 Antibody (FMC63) Inhibitor 95.56% Unkown

Orthologs Information

Species Symbol Source ID
Homo sapiens CD19 NCBI NCBI:930